Short communicationComparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis
Introduction
Since the development of chlorpromazine by Charpentier et al. [1] in 1952 the in vitro antimicrobial activity of this neuroleptic as well as that of others of the phenothiazine series has been frequently demonstrated [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12]. Recently, chlorpromazine and thioridazine have been shown to have activity against multidrug-resistant strains of Mycobacterium tuberculosis [2]. The in vitro activity of phenothiazines takes place at concentrations that exceed those that are clinically achievable. Because phenothiazines are concentrated by macrophages that have phagocytosed mycobacteria and have intracellular activity against mycobacteria [5] we have recommended that the mild phenothiazine, thioridazine, should be employed as an adjuvant for the management of freshly diagnosed infections of M. tuberculosis in patients from areas associated with a high prevalence of MDRTB, at least for the interval during which the antibiotic susceptibility of the isolate is being determined [13]. As this period would be only a few months, side effects associated with the use of neuroleptics are not anticipated. The antimycobacterial activities against MDRTB of commonly employed phenothiazines have not been previously compared in one study.
Section snippets
Phenothiazines
Chlorpromazine (CPZ), thioridazine (THZ), promethazine (PMZ), promazine (PZ) and desipramine (DSP) were purchased from Sigma. Stock solutions and dilutions of each phenothiazine with Bactec 12B medium as the diluent were freshly prepared prior to use in brown flasks and protected from light.
MDRTB strains
The 11 MDRTB strains used in this study came from routine specimens from hospitals in the Lisbon area. The methods used for the isolation, culture, identification and antibiotic susceptibility have been
Results and discussion
The average activity of chlorpromazine, thioridazine, promethazine, promazine and desipramine against 11 MDRTB strains is shown in Fig. 1. Chlorpromazine, a neuroleptic that produces severe and frequent side effects, had the same average activity as the very mild neuroleptic thioridazine. The lowest significant concentration of these two phenothiazines was 1 mg/l and produced an average inhibition of 26% in the amount of 14CO2 produced. At a concentration of 3 mg/l inhibition was 60%. Complete
Acknowledgements
We wish to thank Josefina Almeida and Rosario Bettencourt for their excellent technical assistance during the course of this study.
References (15)
- et al.
Recherches sur les dimethylaminopropyl N-phenothiazines
C. R. Acad. Sci.
(1952) - et al.
Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis
J. Antimicrob. Chemother.
(1996) Contribution a l'etude des properietes antibiotiques de la chlorpromazine ou 4560 RP
Ann. Inst. Pasteur
(1961)- et al.
Antimycobacterial activity of methdilazine (Md): an antimicrobic phenothiazine
Acta Pathol. Micrbiol. Scand.
(1993) - et al.
Chlorpromazine: a drug potentially useful for treating mycobacterial infections
Chemotherapy
(1992) - et al.
In vitro susceptibility testing of Mycobacterium tuberculosis strains to trifluoperazine
J. Chemother.
(1999) - et al.
The antibacterial effect of selected phenothiazines and thioxanthenes on slow growing mycobacteria
Acta Pathol. Microbiol. Scand. B.
(1986)